Stay updated on Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page.

Latest updates to the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the lapse-in-government-funding notice and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding status notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedUI/metadata updates include a new glossary toggle (Show glossary), capitalization tweaks to QC-related labels, and a revision notice showing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; no changes to study content, navigation, or visible features were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated, state-by-state list of study locations (California, Colorado, Florida, Georgia, Illinois, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Rhode Island, South Carolina, Tennessee, Texas, Virginia, and Washington) and updated the record to revision v3.3.3. The per-state location subsections (e.g., California Locations, Colorado Locations) were removed in this update.SummaryDifference2%

- Check78 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2 with no substantive changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page.